Vascular Endothelial Growth Factor and Angiopoietin in Liver Regeneration

Liver architecture remodeling following partial hepatectomy (PHx) involves the formation of a complex network of liver sinusoids through which the blood flows. The present study examines the involvement of vascular endothelial growth factor (VEGF) and angiopoietin-1 (ang-1) during liver regeneration...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemical and biophysical research communications 2001-09, Vol.287 (1), p.209-215
Hauptverfasser: Kraizer, Yehudit, Mawasi, Nidal, Seagal, Jane, Paizi, Melia, Assy, Nimer, Spira, Gadi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 215
container_issue 1
container_start_page 209
container_title Biochemical and biophysical research communications
container_volume 287
creator Kraizer, Yehudit
Mawasi, Nidal
Seagal, Jane
Paizi, Melia
Assy, Nimer
Spira, Gadi
description Liver architecture remodeling following partial hepatectomy (PHx) involves the formation of a complex network of liver sinusoids through which the blood flows. The present study examines the involvement of vascular endothelial growth factor (VEGF) and angiopoietin-1 (ang-1) during liver regeneration. Following PHx, VEGF and ang-1 mRNA levels increase, followed by gradual return to baseline levels. RT-PCR analysis of VEGF mRNA reveals three isoforms, VEGF120, VEGF164 and VEGF188. Of the three, VEGF188 is the predominant isoform, VEGF120 being the less abundant. Although VEGF mRNA fluctuates following PHx, the relative expression of each isoform remains the same throughout the recovery process. The level of neuropilin-1, an accessory receptor of VEGF to main receptor corresponds with that of VEGF and ang-1. We have previously demonstrated the capacity of exogenous VEGF165 to stimulate liver cell proliferation following PHx. We now report similar effect using VEGF121, further demonstrating the benefit of manipulating growth factors where such an intervention is required.
doi_str_mv 10.1006/bbrc.2001.5548
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71152000</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006291X01955482</els_id><sourcerecordid>71152000</sourcerecordid><originalsourceid>FETCH-LOGICAL-c406t-5c6fbe8df04d53c0cc122df129d89f2b7691d68c5cffebbc6635e404b3058dea3</originalsourceid><addsrcrecordid>eNp1kEFLwzAYhoMobk6vHqUnb61J2mbtcQw3BwNBVLyFNPm6RbpkJunEf2_KBp6ED77L877wPgjdEpwRjNlD0ziZUYxJVpZFdYbGBNc4pQQX52iMI5HSmnyM0JX3n5EiBasv0YiQsqjplI3R6l142XfCJY9G2bCFTosuWTr7HbbJQshgXSKMSmZmo-3eagjaJPHW-gAueYENGHAiaGuu0UUrOg83pz9Bb4vH1_lTun5eruazdSoLzEJaStY2UKkWF6rMJZaSUKpaQmtV1S1tpqwmilWylG0LTSMZy0socNHkuKwUiHyC7o-9e2e_evCB77SX0HXCgO09n8ZxUQiOYHYEpbPeO2j53umdcD-cYD7I44M8Psjjg7wYuDs1980O1B9-shWB6ghA3HfQ4LiXGowEpR3IwJXV_3X_AlhDfrQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71152000</pqid></control><display><type>article</type><title>Vascular Endothelial Growth Factor and Angiopoietin in Liver Regeneration</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Kraizer, Yehudit ; Mawasi, Nidal ; Seagal, Jane ; Paizi, Melia ; Assy, Nimer ; Spira, Gadi</creator><creatorcontrib>Kraizer, Yehudit ; Mawasi, Nidal ; Seagal, Jane ; Paizi, Melia ; Assy, Nimer ; Spira, Gadi</creatorcontrib><description>Liver architecture remodeling following partial hepatectomy (PHx) involves the formation of a complex network of liver sinusoids through which the blood flows. The present study examines the involvement of vascular endothelial growth factor (VEGF) and angiopoietin-1 (ang-1) during liver regeneration. Following PHx, VEGF and ang-1 mRNA levels increase, followed by gradual return to baseline levels. RT-PCR analysis of VEGF mRNA reveals three isoforms, VEGF120, VEGF164 and VEGF188. Of the three, VEGF188 is the predominant isoform, VEGF120 being the less abundant. Although VEGF mRNA fluctuates following PHx, the relative expression of each isoform remains the same throughout the recovery process. The level of neuropilin-1, an accessory receptor of VEGF to main receptor corresponds with that of VEGF and ang-1. We have previously demonstrated the capacity of exogenous VEGF165 to stimulate liver cell proliferation following PHx. We now report similar effect using VEGF121, further demonstrating the benefit of manipulating growth factors where such an intervention is required.</description><identifier>ISSN: 0006-291X</identifier><identifier>EISSN: 1090-2104</identifier><identifier>DOI: 10.1006/bbrc.2001.5548</identifier><identifier>PMID: 11549276</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>angiopoietin ; Angiopoietin-1 ; Animals ; Cell Division - drug effects ; Endothelial Growth Factors - blood ; Endothelial Growth Factors - genetics ; Endothelial Growth Factors - metabolism ; Endothelial Growth Factors - pharmacology ; Gene Expression ; Hepatectomy ; liver regeneration ; Liver Regeneration - drug effects ; Liver Regeneration - physiology ; Lymphokines - blood ; Lymphokines - genetics ; Lymphokines - metabolism ; Lymphokines - pharmacology ; Male ; Membrane Glycoproteins - genetics ; Membrane Glycoproteins - metabolism ; Models, Animal ; Nerve Tissue Proteins - metabolism ; neuropilin ; Neuropilin-1 ; partial hepatectomy ; Proliferating Cell Nuclear Antigen - analysis ; Rats ; Rats, Sprague-Dawley ; RNA, Messenger - metabolism ; Vascular Endothelial Growth Factor A ; Vascular Endothelial Growth Factors ; VEGF</subject><ispartof>Biochemical and biophysical research communications, 2001-09, Vol.287 (1), p.209-215</ispartof><rights>2001 Academic Press</rights><rights>Copyright 2001 Academic Press.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c406t-5c6fbe8df04d53c0cc122df129d89f2b7691d68c5cffebbc6635e404b3058dea3</citedby><cites>FETCH-LOGICAL-c406t-5c6fbe8df04d53c0cc122df129d89f2b7691d68c5cffebbc6635e404b3058dea3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0006291X01955482$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11549276$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kraizer, Yehudit</creatorcontrib><creatorcontrib>Mawasi, Nidal</creatorcontrib><creatorcontrib>Seagal, Jane</creatorcontrib><creatorcontrib>Paizi, Melia</creatorcontrib><creatorcontrib>Assy, Nimer</creatorcontrib><creatorcontrib>Spira, Gadi</creatorcontrib><title>Vascular Endothelial Growth Factor and Angiopoietin in Liver Regeneration</title><title>Biochemical and biophysical research communications</title><addtitle>Biochem Biophys Res Commun</addtitle><description>Liver architecture remodeling following partial hepatectomy (PHx) involves the formation of a complex network of liver sinusoids through which the blood flows. The present study examines the involvement of vascular endothelial growth factor (VEGF) and angiopoietin-1 (ang-1) during liver regeneration. Following PHx, VEGF and ang-1 mRNA levels increase, followed by gradual return to baseline levels. RT-PCR analysis of VEGF mRNA reveals three isoforms, VEGF120, VEGF164 and VEGF188. Of the three, VEGF188 is the predominant isoform, VEGF120 being the less abundant. Although VEGF mRNA fluctuates following PHx, the relative expression of each isoform remains the same throughout the recovery process. The level of neuropilin-1, an accessory receptor of VEGF to main receptor corresponds with that of VEGF and ang-1. We have previously demonstrated the capacity of exogenous VEGF165 to stimulate liver cell proliferation following PHx. We now report similar effect using VEGF121, further demonstrating the benefit of manipulating growth factors where such an intervention is required.</description><subject>angiopoietin</subject><subject>Angiopoietin-1</subject><subject>Animals</subject><subject>Cell Division - drug effects</subject><subject>Endothelial Growth Factors - blood</subject><subject>Endothelial Growth Factors - genetics</subject><subject>Endothelial Growth Factors - metabolism</subject><subject>Endothelial Growth Factors - pharmacology</subject><subject>Gene Expression</subject><subject>Hepatectomy</subject><subject>liver regeneration</subject><subject>Liver Regeneration - drug effects</subject><subject>Liver Regeneration - physiology</subject><subject>Lymphokines - blood</subject><subject>Lymphokines - genetics</subject><subject>Lymphokines - metabolism</subject><subject>Lymphokines - pharmacology</subject><subject>Male</subject><subject>Membrane Glycoproteins - genetics</subject><subject>Membrane Glycoproteins - metabolism</subject><subject>Models, Animal</subject><subject>Nerve Tissue Proteins - metabolism</subject><subject>neuropilin</subject><subject>Neuropilin-1</subject><subject>partial hepatectomy</subject><subject>Proliferating Cell Nuclear Antigen - analysis</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>RNA, Messenger - metabolism</subject><subject>Vascular Endothelial Growth Factor A</subject><subject>Vascular Endothelial Growth Factors</subject><subject>VEGF</subject><issn>0006-291X</issn><issn>1090-2104</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kEFLwzAYhoMobk6vHqUnb61J2mbtcQw3BwNBVLyFNPm6RbpkJunEf2_KBp6ED77L877wPgjdEpwRjNlD0ziZUYxJVpZFdYbGBNc4pQQX52iMI5HSmnyM0JX3n5EiBasv0YiQsqjplI3R6l142XfCJY9G2bCFTosuWTr7HbbJQshgXSKMSmZmo-3eagjaJPHW-gAueYENGHAiaGuu0UUrOg83pz9Bb4vH1_lTun5eruazdSoLzEJaStY2UKkWF6rMJZaSUKpaQmtV1S1tpqwmilWylG0LTSMZy0socNHkuKwUiHyC7o-9e2e_evCB77SX0HXCgO09n8ZxUQiOYHYEpbPeO2j53umdcD-cYD7I44M8Psjjg7wYuDs1980O1B9-shWB6ghA3HfQ4LiXGowEpR3IwJXV_3X_AlhDfrQ</recordid><startdate>20010914</startdate><enddate>20010914</enddate><creator>Kraizer, Yehudit</creator><creator>Mawasi, Nidal</creator><creator>Seagal, Jane</creator><creator>Paizi, Melia</creator><creator>Assy, Nimer</creator><creator>Spira, Gadi</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20010914</creationdate><title>Vascular Endothelial Growth Factor and Angiopoietin in Liver Regeneration</title><author>Kraizer, Yehudit ; Mawasi, Nidal ; Seagal, Jane ; Paizi, Melia ; Assy, Nimer ; Spira, Gadi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c406t-5c6fbe8df04d53c0cc122df129d89f2b7691d68c5cffebbc6635e404b3058dea3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>angiopoietin</topic><topic>Angiopoietin-1</topic><topic>Animals</topic><topic>Cell Division - drug effects</topic><topic>Endothelial Growth Factors - blood</topic><topic>Endothelial Growth Factors - genetics</topic><topic>Endothelial Growth Factors - metabolism</topic><topic>Endothelial Growth Factors - pharmacology</topic><topic>Gene Expression</topic><topic>Hepatectomy</topic><topic>liver regeneration</topic><topic>Liver Regeneration - drug effects</topic><topic>Liver Regeneration - physiology</topic><topic>Lymphokines - blood</topic><topic>Lymphokines - genetics</topic><topic>Lymphokines - metabolism</topic><topic>Lymphokines - pharmacology</topic><topic>Male</topic><topic>Membrane Glycoproteins - genetics</topic><topic>Membrane Glycoproteins - metabolism</topic><topic>Models, Animal</topic><topic>Nerve Tissue Proteins - metabolism</topic><topic>neuropilin</topic><topic>Neuropilin-1</topic><topic>partial hepatectomy</topic><topic>Proliferating Cell Nuclear Antigen - analysis</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>RNA, Messenger - metabolism</topic><topic>Vascular Endothelial Growth Factor A</topic><topic>Vascular Endothelial Growth Factors</topic><topic>VEGF</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kraizer, Yehudit</creatorcontrib><creatorcontrib>Mawasi, Nidal</creatorcontrib><creatorcontrib>Seagal, Jane</creatorcontrib><creatorcontrib>Paizi, Melia</creatorcontrib><creatorcontrib>Assy, Nimer</creatorcontrib><creatorcontrib>Spira, Gadi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biochemical and biophysical research communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kraizer, Yehudit</au><au>Mawasi, Nidal</au><au>Seagal, Jane</au><au>Paizi, Melia</au><au>Assy, Nimer</au><au>Spira, Gadi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Vascular Endothelial Growth Factor and Angiopoietin in Liver Regeneration</atitle><jtitle>Biochemical and biophysical research communications</jtitle><addtitle>Biochem Biophys Res Commun</addtitle><date>2001-09-14</date><risdate>2001</risdate><volume>287</volume><issue>1</issue><spage>209</spage><epage>215</epage><pages>209-215</pages><issn>0006-291X</issn><eissn>1090-2104</eissn><abstract>Liver architecture remodeling following partial hepatectomy (PHx) involves the formation of a complex network of liver sinusoids through which the blood flows. The present study examines the involvement of vascular endothelial growth factor (VEGF) and angiopoietin-1 (ang-1) during liver regeneration. Following PHx, VEGF and ang-1 mRNA levels increase, followed by gradual return to baseline levels. RT-PCR analysis of VEGF mRNA reveals three isoforms, VEGF120, VEGF164 and VEGF188. Of the three, VEGF188 is the predominant isoform, VEGF120 being the less abundant. Although VEGF mRNA fluctuates following PHx, the relative expression of each isoform remains the same throughout the recovery process. The level of neuropilin-1, an accessory receptor of VEGF to main receptor corresponds with that of VEGF and ang-1. We have previously demonstrated the capacity of exogenous VEGF165 to stimulate liver cell proliferation following PHx. We now report similar effect using VEGF121, further demonstrating the benefit of manipulating growth factors where such an intervention is required.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>11549276</pmid><doi>10.1006/bbrc.2001.5548</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-291X
ispartof Biochemical and biophysical research communications, 2001-09, Vol.287 (1), p.209-215
issn 0006-291X
1090-2104
language eng
recordid cdi_proquest_miscellaneous_71152000
source MEDLINE; Elsevier ScienceDirect Journals
subjects angiopoietin
Angiopoietin-1
Animals
Cell Division - drug effects
Endothelial Growth Factors - blood
Endothelial Growth Factors - genetics
Endothelial Growth Factors - metabolism
Endothelial Growth Factors - pharmacology
Gene Expression
Hepatectomy
liver regeneration
Liver Regeneration - drug effects
Liver Regeneration - physiology
Lymphokines - blood
Lymphokines - genetics
Lymphokines - metabolism
Lymphokines - pharmacology
Male
Membrane Glycoproteins - genetics
Membrane Glycoproteins - metabolism
Models, Animal
Nerve Tissue Proteins - metabolism
neuropilin
Neuropilin-1
partial hepatectomy
Proliferating Cell Nuclear Antigen - analysis
Rats
Rats, Sprague-Dawley
RNA, Messenger - metabolism
Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factors
VEGF
title Vascular Endothelial Growth Factor and Angiopoietin in Liver Regeneration
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T09%3A22%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Vascular%20Endothelial%20Growth%20Factor%20and%20Angiopoietin%20in%20Liver%20Regeneration&rft.jtitle=Biochemical%20and%20biophysical%20research%20communications&rft.au=Kraizer,%20Yehudit&rft.date=2001-09-14&rft.volume=287&rft.issue=1&rft.spage=209&rft.epage=215&rft.pages=209-215&rft.issn=0006-291X&rft.eissn=1090-2104&rft_id=info:doi/10.1006/bbrc.2001.5548&rft_dat=%3Cproquest_cross%3E71152000%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71152000&rft_id=info:pmid/11549276&rft_els_id=S0006291X01955482&rfr_iscdi=true